1/29
Vocabulary practice cards covering pharmaceutical innovation, FDA regulatory tradeoffs, cost-effectiveness analysis, international health systems, and US health insurance programs.
Pharmaceutical Patent
A temporary legal monopoly that protects an original drug innovation, lasting 17 years in Problem Set 6 to reward research and innovation.
Induced Innovation
A phenomenon where firms direct their research and development toward areas where they expect greater profits.
Type I FDA Error
An error that occurs when the FDA approves a drug that is unsafe or ineffective, illustrated by the approval of Vioxx.
Type II FDA Error
An error that occurs when the FDA rejects a drug that is safe and effective, which increases when approval standards are too strict.
Quality-Adjusted Life Year (QALY)
A health outcome metric that combines both the length of life and the quality of life produced by an intervention.
Incremental Cost-Effectiveness Ratio (ICER)
A ratio calculated as extra cost divided by extra health benefit, measuring the cost of one additional unit of effectiveness (such as one QALY) when comparing two options.
Average Cost-Effectiveness Ratio (ACER)
A metric that measures the cost-effectiveness ratio for one treatment compared specifically with no treatment.
Cost-Effectiveness Frontier (CEF)
The set of potentially cost-effective treatment options, excluding dominated choices.
Dominated Treatment
A treatment option that costs more and provides less effectiveness than an alternative option.
Value of Statistical Life (VSL)
The monetary value inferred from individuals' willingness to pay for small reductions in mortality risk, rather than willingness to accept certain death.
Beveridge Health System
A tax-funded universal health care model, generally with the government serving as a single payer, exemplified by the United Kingdom.
Single-Payer Insurance
A system where the government provides health insurance and directly pays almost all medical bills.
Gatekeeping
A healthcare system requirement where a patient must obtain a referral from a general practitioner (GP) before seeing a medical specialist.
UK Postcode Lottery
A historical circumstance in the United Kingdom where a patient's access to healthcare providers depended heavily on where they lived.
Bismarck Health System
A universal healthcare model based on regulated competition among private nonprofit sickness funds, using uniform or government-set prices.
Managed Competition
A framework of regulated competition among health insurers designed to improve performance and control healthcare costs.
Community Rating
An insurance pricing principle in which premium rates are not based on individual health risk.
Medicaid
A public health insurance program funded jointly by federal and state governments primarily for low-income individuals, prioritizing children and pregnant women.
Medicare
A federal health insurance program in the United States primarily covering older adults and certain individuals with disabilities.
Employer-Sponsored Insurance (ESI)
The most common source of US health insurance, which grew as a tax-favored fringe benefit whose premiums are excluded from taxable employee compensation.
Job Lock
A condition in which employees hesitate to leave or change jobs due to the fear of losing their employer-sponsored health insurance.
Medicare Part A
The branch of Medicare that covers inpatient hospital expenses.
Medicare Part B
The branch of Medicare that covers physician services and outpatient medical expenses.
Medicare Part D
The branch of Medicare that covers prescription drugs, which are not automatically covered under traditional Medicare.
Poverty Trap
An economic disincentive that occurs when earning higher income causes a loss of means-tested benefits, reducing the net financial payoff of working more.
ACA Modified Community Rating
An Affordable Care Act rule barring insurers from varying premiums based on health status, while allowing variations based on age.
ACA Individual Mandate
A legal requirement to maintain health insurance or pay a penalty, which was reduced to $0 at the federal level in 2019.
Cream-Skimming
The practice by health insurers of designing plans, provider networks, or marketing strategies to attract healthier, lower-cost enrollees.
ACA Risk Adjustment
A system of financial transfers among insurance plans designed to neutralize incentives for cream-skimming healthier enrollees.
Medical Consumer Price Index (CPI) Problem
The difficulty in accurately measuring healthcare prices because quality enhancements and novel therapies (such as a newly developed cure for Hodgkin lymphoma) make simple average price changes misleading.